ACC 2021 Discussion: Benefits of SGLT1/2 Inhibition Across the Full Spectrum of EF

Просмотров: 568   |   Загружено: 3 год.
icon
Radcliffe Cardiology
icon
4
icon
Скачать
iconПодробнее о видео
Dr Harriette Van Spall (McMaster University, Hamilton, CA) and Dr Deepak L Bhatt (Brigham and Women's Hospital, Boston, MA, US) discussed the latest data on the benefits of SGLT2/1 inhibition across the full spectrum of ejection fraction, including HFpEF.

Recorded remotely from Boston and Hamilton, 2021.

Editor: Mirjam Boros

Похожие видео

Добавлено: 55 год.
Добавил:
  © 2019-2021
  ACC 2021 Discussion: Benefits of SGLT1/2 Inhibition Across the Full Spectrum of EF - RusLar.Me